Device
Active anodal tDCS
Active anodal tDCS is a medical device with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
100%(3 trials)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
completed360%
withdrawn120%
recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingnot_applicable
Learning Study: Improving Vision in Adults With Macular Degeneration
NCT04762368
withdrawnnot_applicable
Investigating Memory Retrieval Improvement in Healthy Subjects
NCT03312920
completednot_applicable
Stimulating the Brain to Improve Self-Awareness
NCT03370341
completednot_applicable
Stimulating the Social Brain
NCT03374631
completednot_applicable
Improving Visual Attention in Schizophrenia
NCT03880227
Clinical Trials (5)
Showing 5 of 5 trials
NCT04762368Not Applicable
Learning Study: Improving Vision in Adults With Macular Degeneration
NCT03312920Not Applicable
Investigating Memory Retrieval Improvement in Healthy Subjects
NCT03370341Not Applicable
Stimulating the Brain to Improve Self-Awareness
NCT03374631Not Applicable
Stimulating the Social Brain
NCT03880227Not Applicable
Improving Visual Attention in Schizophrenia
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5